Glo-BNHL: BMS Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma

Project Details

Short titleGlo-BNHL: BMS Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma
StatusNot started
Effective start/end date1/05/2531/10/29

Funding

  • BRISTOL MYERS SQUIBB PHARMACEUTICALS